Podcast

Elliott Fegelman, MD, on J&J's Ethicon Announcement: "Project Game Changer"

08/30/2017

Dr. Elliott Fegelman, therapeutic area lead for Metabolics at Johnson & Johnson Innovation, discusses "Project Game Changer" and what it means for the future of bariatric surgery.

Also presented at the 22nd World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders.

For more content on bariatric surgery, visit our Medical Resource Center. 

Related Content

Allergy & Immunology
Allergy & Immunology
William Silvers, MD, on Diagnosing Marijuana Allergy
11/28/2018
Dr William Silvers from the University of Colorado School of Medicine discusses Cannabis sativa allergy - clinical manifestations, diagnosis options, misconceptions, and cases he has seen in his own...
11/28/2018
Cardiovascular Diseases
Cardiovascular Diseases
Expert Conversations: How to Choose and Initiate a Novel Agent for Patients With CVD and Diabetes
04/21/2020
In this podcast, Ralph Brindis, MD, MPH, interviews Laurence Sperling, MD, about treating patients with cardiovascular disease and diabetes—with a special focus on how to choose the appropriate novel...
04/21/2020
HIV Management
HIV Management
Barriers to ART Adherence Post-Incarceration
08/26/2022
In this podcast, Tawandra Rowell-Cunsolo, PhD, discusses her recent study, which identified 4 barriers to optimal antiretroviral therapy adherence among individuals with HIV who were formerly incarcerated,...
08/26/2022
Urology
Urology
Andrew Meltzer, MD, on Ureteral Stones: Should the Guidelines Be Revised?
06/25/2018
Andrew Meltzer, MD, from the George Washington University School of Medicine and Health Sciences, discusses his latest research, which suggests that the guideline-recommended medication tamsulosin may not...
06/25/2018
Epilepsy
Epilepsy
Emily Johnson, MD, on Late-Onset Epilepsy
01/24/2019
Dr Emily Johnson from Johns Hopkins University School of Medicine talks about her research on late-onset epilepsy, the midlife risk factors that may contribute to late-onset epilepsy, and more.
01/24/2019